Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 1, 1998, Pages 180-183

  Bermudez, Luiz E ^a   Petrofsky, Mary ^a   Kolonoski, Peter ^a   Young, Lowell S ^a  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPLEEN;

EID: 0031982891     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.1.180     Document Type: Article

References (22)

1. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Petrofsky, and L. S. Young. 1994. Clarithromycin, dapsone and their combination to treat or prevent disseminated Mycobacterium avium complex in beige mice. Antimicrob. Agents Chemother. 38:2717-2722.
2. Bermudez, L. E., K. A. Nash, M. Petrofsky, L. S. Young, and C. B. Inderlied. 1996. Effect of ethambutol on emergence of clarithromycin-rcsistant Mycobacterium avium complex in the beige mouse model. J. Infect. Dis. 174:1218-1222.
3. Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, F. R. Sattler, and AIDS Clinical Trials Group. 1994. Clarithromycin therapy for bacteremic Mycobacterium avium complex. Ann. Intern. Med. 121:905-911.
4. Cynamon, M. H., and S. P. Klemens. 1992. Activity of azithromycin against Mycobacterium avium infection in beige mice. Antimicrob. Agents Chemother. 36:1611-1618.
5. Dautzenberg, B., C. Truffot, S. Legris, M. C. Meyohas, H. C. Berlie, A. Mercat, S. Chevret, and J. Grosset. 1991. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. Am. Rev. Respir. Dis. 144:564-569.
6. Doucet-Populaire, F., R. Goldman, J. Grosset, and V. Jarlier. 1995. Molecular basis of clarithromycin activity against Mycobacterium avium, abstr. C93, p. 56. In Program and abstracts of 35th International Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Fernandes, P. B., D. J. Hardy, D. McDaniel, C. W. Hanson, and R. N. Swanson. 1989. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob. Agents Chemother. 33:1531-1536.
8. Havlir, D. V., M. P. Dube, F. R. Sattler, D. N. Fortal, C. A. Demper, M. W. Dunne, D. M. Parenti, J. P. Lavelle, A. C. White, Jr., M. D. Witt, S. A. Bozzette, J. A. McCutchan, and California Clinical Trials Group. 1996. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N. Engl. J. Med. 335:392-398.
9. Heifets, L. B., P. J. Lindholm-Levy, and R. D. Comstock. 1992. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. Am. Rev. Respir. Dis. 145:856-858.
10. Horsburgh, C. R., Jr. 1991. Mycobacterium avium complex in the acquired immunodeficiency syndrome (AIDS). N. Engl. J. Med. 324:1332-1338.
11. Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310.
12. Inderlied, C. B., P. T. Kolonoski, M. Wu, and L. S. Young. 1989. In vitro and in vivo activity of azithromycin (CP 62, 993) against the Mycobacterium avium complex. J. Infect. Dis. 159:994-997.
13. Ji, B., N. Lounis, C. Truffot-Pernot, and J. Grosset. 1992. Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. Antimicrob. Agents Chemother. 36:2839-2840.
14. Klemens, S. P., M. S. DeStefano, and M. H. Cynamon. 1992. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 36:2413-2417.
15. Meier, A., P. Kirschner, B. Springer, V. A. Steingrube, B. A. Brown, R. J. Wallace, Jr., and E. C. Böttger. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384.
16. Nash, K. A., and C. B. Inderlied. 1995. The genetic basis of macrolide resistance in Mycobacterium avium. Antimicrob. Agents Chemother. 39:2625-2630.
17. Nightingale, S. D., L. T. Byrd, P. M. Southern, J. D. Jockusch, S. X. Cal, and B. Wynne. 1992. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J. Infect. Dis. 165:1082-1085.
18. Nightingale, S. D., D. W. Cameron, F. M. Gordin, P. M. Sullam, D. L. Cohn, R. Chaisson, L. J. Eron, P. D. Sparti, B. Bihari, D. L. Kaufman, J. J. Stern, D. D. Pearce, W. G. Winberg, A. LaMarca, and F. P. Siegal. 1993. Two placebo controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N. Engl. J. Med. 329:828-833.
19. Pierce, M., S. Crampton, D. Henry, L. Hiefets, A. LaMarca, M. Montecalvo, G. P. Wormser, H. Jablonowski, J. J., M. Cynamon, B. G. Yangco, G. Notario, and J. C. Craft. 1996. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N. Engl. J. Med. 335:384-391.
20. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
21. Ward, T., D. Rimland, M. Huycke, and C. Kauffman. 1996. Randomized open label trial of azithromycin plus ethambutol versus clarithromycin plus ethambutol therapy of MAC bacteremia in AIDS, p. 21. In Program and abstracts of 34th Infectious Diseases Society of America Meeting, Alexandria, Va.
22. Young, L. S., L. Wiviott, M. Wu, P. T. Kolonoski, R. Bolan, and C. B. Inderlied. 1991. Azithromycin reduces Mycobacterium avium complex bacteremia and relieves the symptoms of disseminated disease in patients with AIDS. Lancet 338:1107-1109.